Drug
En3285
En3285: highest development phase Phase 3, developed by Endo. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Endo
Trials
| Drug | Phase | Indication |
|---|---|---|
| EN3285 NCT00574860 | Phase 3 | Oral Mucositis |
Latest
No recent events.
Follow En3285 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.